Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ABCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PTPN22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRBC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BCL7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANTXR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XKR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928618 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on